alpha-1 antitrypsin deficiency
In a bid to expand recognition and treatment of alpha-1 antitrypsin deficiency, a cause of COPD, Grifols is making its over-the-counter genetic test available for free.
FDA Clears Grifols AAT Deficiency Test, OraSure Saliva Collection Device for Over-the-Counter Use
The test screens for genetic mutations commonly associated with the condition and can now be used with OraSure Technologies' ORAcollect Dx collection device.
Grifols Wins FDA Approval for AAT Deficiency Test
The test is designed to detect 14 of the most prevalent mutations in the gene responsible for the disease.